rakuten left binance left net_left adver left

Acasti Pharma: Low Chance of a Rebound

Shares of Acasti Pharma , Inc. (NASDAQ:ACST) have dropped 23.7% year-to-date, trading at $2.44 on Monday. This comes upon disappointing results from some clinical trials, and a...
Acasti Pharma: Low Chance of a Rebound © Reuters. Acasti Pharma: Low Chance of a Rebound

Shares of Acasti Pharma , Inc. (NASDAQ:ACST) have dropped 23.7% year-to-date, trading at $2.44 on Monday.

This comes upon disappointing results from some clinical trials, and a reverse stock split.

To boost its stock price, the company will need to produce some facts to trigger some optimism on the market. Without this, shares will are unlikely to move significantly from their current levels. Thus, I am neutral on this stock for the time being.

Following its merger with Grace Therapeutics, Inc., on Aug. 27, 2021, Acasti is now a late-stage specialty biopharmaceutical company focusing on rare and orphan diseases. Previous to the merger, Acasti was a clinical-stage developer of an omega-3 fatty acids-based treatment for patients with severe hypertriglyceridemia (i.e., very high levels of triglycerides in the blood).

Acasti now develops novel delivery technologies to improve the effectiveness of currently marketed treatments for post-herpetic neuralgia, subarachnoid hemorrhages, and ataxia-telangiectasia. (See ACST stock charts on TipRanks)

Q1 FY2022 Results

Acasti reported a net loss of $3.1 million, or $0.01 per common share for the three months ended June 30, 2021, compared to a loss of $4.7 million ($0.05 per share) a year ago.

The company reported nearly $60 million in cash on hand and cash equivalents, which it projects as enough to fund another two years of development and research activities.

Poor Long-Term Perspectives

Acasti was working on treatments for patients with severe hypertriglyceridemia, but it suspended activities following disappointing data from two clinical trials called TRILOGY 1 and TRILOGY 2.

This produced a sharp drop in the stock price, which required a corporate action consisting of an 8-to-1 reverse stock split to comply with the Nasdaq minimum bid price rule again, effective on August 27.

There is a plan in the works to combine the data from TRILOGY 1 with the data from TRILOGY 2. From the pooling, the company could derive better statistics, and potentially study the treatment further.

If successful, these solutions could produce some upside in the stock price in the short-term. However, such a likelihood is low.

Wall Street’s Take

The stock has a TipRanks Smart Score of 1 out of 10, indicating that the stock returns are likely to underperform the overall market.

This is the result of a very negative investors sentiment, and negative technicals.

Summary

Disappointing results from clinical trials threw the stock down. Alternatives are being examined to raise the value of the stock.

The price should continue to trade approximately in line with current values going forward.

Disclosure: At the time of publication, Alberto Abaterusso did not have a position in any of the securities mentioned in this article.

Disclaimer: The information contained in this article represents the views and opinion of the writer only, and not the views or opinion of TipRanks or its affiliates, and should be considered for informational purposes only. TipRanks makes no warranties about the completeness, accuracy or reliability of such information. Nothing in this article should be taken as a recommendation or solicitation to purchase or sell securities. Nothing in the article constitutes legal, professional, investment and/or financial advice and/or takes into account the specific needs and/or requirements of an individual, nor does any information in the article constitute a comprehensive or complete statement of the matters or subject discussed therein. TipRanks and its affiliates disclaim all liability or responsibility with respect to the content of the article, and any action taken upon the information in the article is at your own and sole risk. The link to this article does not constitute an endorsement or recommendation by TipRanks or its affiliates. Past performance is not indicative of future results, prices or performance.

ig right nyse right Neteller adver right
APPROVED BROKERS
Row 1 Left net_home_top Row 1 Right Row 2 Left Row 2 Center Row 2 Right Main Right TOP 07 Main Right TOP 06 Main Right TOP 05 Main Right TOP 04 Main Right TOP 03 Main Right TOP 01
28-09-2021 06:04:14 (UTC+7)

EUR/USD

1.1695

+0.0001 (+0.01%)

Summary

↑ Sell

Moving Avg:

Buy (2)

Sell (10)

Indicators:

Buy (1)

Sell (6)

EUR/USD

1.1695

+0.0001 (+0.01%)

Summary

↑ Sell

Moving Avg:

Buy (2)

Sell (10)

Indicators:

Buy (1)

Sell (6)

GBP/USD

1.3702

+0.0008 (+0.05%)

Summary

↑ Buy

Moving Avg:

Buy (8)

Sell (4)

Indicators:

Buy (6)

Sell (0)

USD/JPY

110.99

-0.01 (-0.01%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (1)

Sell (4)

AUD/USD

0.7286

0.0001 (0.00%)

Summary

Neutral

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (4)

Sell (1)

USD/CAD

1.2627

0.0000 (0.00%)

Summary

Buy

Moving Avg:

Buy (9)

Sell (3)

Indicators:

Buy (4)

Sell (3)

EUR/JPY

129.81

+0.03 (+0.02%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (1)

Sell (6)

EUR/CHF

1.0827

+0.0004 (+0.04%)

Summary

↑ Sell

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (1)

Sell (6)

Gold Futures

1,751.00

+1.15 (+0.07%)

Summary

Neutral

Moving Avg:

Buy (8)

Sell (4)

Indicators:

Buy (3)

Sell (4)

Silver Futures

22.650

+0.013 (+0.06%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (9)

Sell (0)

Copper Futures

4.2787

-0.0010 (-0.02%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (8)

Sell (1)

Crude Oil WTI Futures

75.34

-0.07 (-0.09%)

Summary

↑ Sell

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (1)

Sell (7)

Brent Oil Futures

78.62

+0.01 (+0.01%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (4)

Sell (1)

Natural Gas Futures

5.912

+0.052 (+0.89%)

Summary

Neutral

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (1)

Sell (8)

US Coffee C Futures

194.98

+0.63 (+0.32%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (5)

Sell (0)

Euro Stoxx 50

4,165.48

+6.97 (+0.17%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (9)

S&P 500

4,443.11

-12.37 (-0.28%)

Summary

↑ Sell

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (0)

Sell (9)

DAX

15,573.88

+42.13 (+0.27%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (8)

FTSE 100

7,063.40

+11.92 (+0.17%)

Summary

↑ Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (1)

Sell (7)

Hang Seng

24,208.78

+16.62 (+0.07%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (8)

Sell (0)

US Small Cap 2000

2,281.79

+33.71 (+1.50%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (7)

IBEX 35

9,002.90

+129.80 (+1.46%)

Summary

Buy

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (4)

Sell (2)

BASF SE NA O.N.

64.740

+1.040 (+1.63%)

Summary

↑ Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (1)

Sell (5)

Bayer AG NA

47.47

+0.99 (+2.13%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (9)

Sell (0)

Allianz SE VNA O.N.

196.19

+3.85 (+2.00%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (6)

Sell (2)

Adidas AG

278.80

-2.77 (-0.98%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (10)

Deutsche Lufthansa AG

6.561

+0.328 (+5.26%)

Summary

↑ Buy

Moving Avg:

Buy (11)

Sell (1)

Indicators:

Buy (7)

Sell (2)

Siemens AG Class N

147.27

-0.84 (-0.57%)

Summary

↑ Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (0)

Sell (10)

Deutsche Bank AG

11.120

+0.285 (+2.63%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (5)

Sell (3)

 EUR/USD1.1695↑ Sell
 GBP/USD1.3702↑ Buy
 USD/JPY110.99↑ Sell
 AUD/USD0.7286Neutral
 USD/CAD1.2627Buy
 EUR/JPY129.81↑ Sell
 EUR/CHF1.0827↑ Sell
 Gold1,751.00Neutral
 Silver22.650↑ Buy
 Copper4.2787↑ Buy
 Crude Oil WTI75.34↑ Sell
 Brent Oil78.62↑ Buy
 Natural Gas5.912Neutral
 US Coffee C194.98↑ Buy
 Euro Stoxx 504,165.48↑ Sell
 S&P 5004,443.11↑ Sell
 DAX15,573.88↑ Sell
 FTSE 1007,063.40↑ Sell
 Hang Seng24,208.78↑ Buy
 Small Cap 20002,281.79↑ Sell
 IBEX 359,002.90Buy
 BASF64.740↑ Sell
 Bayer47.47↑ Buy
 Allianz196.19↑ Buy
 Adidas278.80↑ Sell
 Lufthansa6.561↑ Buy
 Siemens AG147.27↑ Sell
 Deutsche Bank AG11.120↑ Buy
Mua/Bán 1 chỉ SJC
# So hôm qua # Chênh TG
SJC Eximbank5,665/ 5,715
(0/ 0) # 900
SJC HCM5,635/ 5,700
(0/ 0) # 885
SJC Hanoi5,635/ 5,702
(0/ 0) # 887
SJC Danang5,635/ 5,702
(0/ 0) # 887
SJC Nhatrang5,635/ 5,702
(0/ 0) # 887
SJC Cantho5,635/ 5,702
(0/ 0) # 887
Cập nhật 28-09-2021 06:04:17
Xem lịch sử giá vàng SJC: nhấn đây!
ↀ Giá vàng thế giới
$1,751.42+1.930.11%
Live 24 hour Gold Chart
ʘ Giá bán lẻ xăng dầu
Sản phẩmVùng 1Vùng 2
RON 95-IV2204022480
RON 95-II,III2194022370
E5 RON 92-II2071021120
DO 0.05S1658016910
DO 0,001S-V1693017260
Dầu hỏa1564015950
ↂ Giá dầu thô thế giới
WTI$75.18-0.49-0.66%
Brent$78.60-0.59-0.76%
$ Tỷ giá Vietcombank
Ngoại tệMua vàoBán ra
USD22.630,0022.860,00
EUR25.993,7727.346,60
GBP30.324,2231.591,18
JPY200,45212,05
KRW16,7520,39
Cập nhật lúc 05:57:45 28/09/2021
Xem bảng tỷ giá hối đoái
binance main right Fxpro aetos main right adver main right